| Combined Chemotherapeutics | Drug delivery system | Type of cancer | Ref. |
|---|---|---|---|
| Doxorubicin and curcumin | Lipid nanoparticles | Hepatoma carcinoma | [48] |
| Doxorubicin and sorafenib | Lipid-polymer hybrid nanoparticles | Hepatocellular carcinoma | [49] |
| Axitinib and celastrol | PEGylated lipid bilayer-supported mesoporous silica nanoparticles | Squamous carcinoma, breast cancer, neuroblastoma | [50] |
| Paclitaxel and curcumin | PEGylated hybrid liposomes-albumin nanoparticles | Breast cancer, melanoma cells | [51] |
| Sorafenib and quercetin | RGD peptide modified lipid coated nanoparticles | Hepatocellular carcinoma | [52] |